Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Imigran Injection
Risk Category
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Selective serotonin receptor agonist for treatment of migraine.
  • Fetal Risk
    Fetal Risk
  • teratogenic in animals causing cervicothoracic vascular defects, and minor skeletal anomalies and embryolethal at high doses.
  • Unknown transfer through the placenta and no adequate human data but reported some congenital anomalies in early pregnancy exposure to the drug including: chromosomal anomalies, phocomelia and growth retardation.
  • Breast Feeding
    Breast Feeding
  • Sumatriptan is excreted in human breast milk following subcutaneous administration.
  • Infant exposure to Sumatriptan can be minimized by avoiding breastfeeding for 12 hours after treatment with Sumatriptan succinate tablets.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     4   +   3    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year